KD Pharma Group Press Releases

• Published on October 2, 2024 - 17:13 GMT

  

  O3 Holding GmbH (KD Pharma Group) successfully placed senior secured bond

  KD Pharma Group successfully placed a senior secured bond with an issue volume of EUR 180 million and a maturity of 5 years BIOGGO, SWITZERLAND, October 2, 2024 /⁨EINPresswire.com⁩/ -- NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR …

  Distribution channels: ...
• Published on October 1, 2024 - 06:00 GMT

  

  KD Pharma Group completes acquisition of dsm-firmenich's Marine Lipids business

  The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world BIOGGO, TICINO, SWITZERLAND, October 1, 2024 /⁨EINPresswire.com⁩/ -- The KD Pharma Group, a leading CDMO in pharmaceutical and nutritional lipids, and dsm-firmenich …

  Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
• Published on July 18, 2024 - 16:15 GMT

  

  KD Pharma Group to acquire dsm-firmenich’s marine lipids business in exchange for a minority stake in the company

  The transaction expands KD Pharma Group‘s lipids CDMO business and includes the MEG-3® fish oil omega-3 product portfolio and two associated production sites BIOGGO, EUROPE, SWITZERLAND, July 18, 2024 /⁨EINPresswire.com⁩/ -- The KD Pharma Group, a leading …

  Distribution channels: Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry ...
• Published on October 19, 2021 - 12:45 GMT

  

  KD PHARMA FURTHER EXPANDS ITS CDMO CAPABILITIES IN THE UK MANUFACTURING SITE

  BIOGGIO, SWITZERLAND, October 19, 2021 /⁨EINPresswire.com⁩/ -- The KD Pharma Group has completed an expansion of its manufacturing site in Seal Sands, United Kingdom. The new modern plant followed a fast-track build project and triples the capacity of the …

  Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...
• Published on October 6, 2021 - 11:17 GMT

  KD Pharma Group Acquires 51% Stake in Trigal Pharma

  BIOGGIO, SWITZERLAND, October 6, 2021 /⁨EINPresswire.com⁩/ -- The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on September 30, 2021 - 10:45 GMT

  KD Pharma Group Welcomes Daniel Wiley as Vice President of Special Projects

  BIOGGIO, TICINO, SWITZERLAND, September 30, 2021 /⁨EINPresswire.com⁩/ -- The KD Pharma Group today announced the appointment of Daniel Wiley as Vice President of Special Projects with responsibility to lead growth projects in algal omega-3 lipids, …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on April 12, 2021 - 12:45 GMT

  

  KD Pharma Acquires Phytoextract and CBD Manufacturing Assets

  Transaction advances KD Pharma’s cannabinoid manufacturing strategy BIOGGIO, LUGANO, SWITZERLAND , April 12, 2021 /⁨EINPresswire.com⁩/ -- The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The assets give …

  Distribution channels: Banking, Finance & Investment Industry, Chemical Industry ...